Reconstructed IPD meta-analysis showed chemoimmunotherapy improved OS and PFS versus PD-(L)1 monotherapy within PD-L1–high disease, with consistent findings across multiple analytic approaches and ...
This segment brings together two essential threads — the broader context of lorlatinib's remarkable durability relative to ...
This segment addresses one of the most practically important aspects of lorlatinib therapy — its distinct and manageable ...
Cohorts included 1,653 AL, 1,055 ATTRwt-CM, and 59 dual-diagnosis patients; only 53%–66% had any relevant test documented, and just 40%–49% had AL-specific workups. Complete monoclonal protein testing ...
In SYNCHRONIZE-MASLD (n=218), 84.2% on weekly survodutide 6.0 mg achieved ≥30% relative liver fat reduction versus 24.3% with placebo at week 48. Liver fat normalization occurred in ~61% of ...
Sponsored by Esperion. Newsletter Get the latest industry news, event updates and more from Managed Healthcare Executive.
Kutscher says MDVIP is expanding into specialty care and eyeing pediatrics. Your browser does not support the audio element.
Positive symptoms correlated with more negative sentiment and longer utterances, whereas negative symptoms aligned with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results